Additional insights into pergolide-associated valvular heart disease.
Lanier
William L
WL
D016907:Adverse Drug Reaction Reporting Systems / Q000592:standards*; D018491:Dopamine Agonists / Q000009:adverse effects*; D019317:Evidence-Based Medicine / Q000592:standards; D005355:Fibrosis / Q000139:chemically induced; D006349:Heart Valve Diseases / Q000139:chemically induced* / Q000453:epidemiology* / Q000378:metabolism / Q000473:pathology; D006801:Humans; D015994:Incidence; D010479:Pergolide / Q000009:adverse effects*; D012042:Registries; D012701:Serotonin / Q000378:metabolism
D018491:Dopamine Agonists; D010479:Pergolide; D012701:Serotonin